IVCAF Investcorp AI Acquisition Corp.
Price Chart
Executive Summary
Investcorp AI Acquisition Corp. (IVCAF) filed an 8-K/A to correct narrative disclosure regarding the Sponsor Support Agreement related to its business combination with Blue Finance Technology Holding Limited. The deal structure, consideration, and closing conditions remain unchanged from the original April 8, 2026 announcement. This is a routine administrative correction with no material impact on deal economics or timeline.
Key Financial Metrics
Actionable Insight
This is a non-event for traders — the amendment corrects only narrative disclosure. Monitor for the F-4 registration statement effectiveness and shareholder vote timeline, which are the next catalysts. No change to deal probability or valuation.
Key Facts
- Filing is an amendment (8-K/A) to correct narrative disclosure on the Sponsor Support Agreement — no substantive changes to the business combination terms.
- Business combination involves IVCA merging with Blue Finance via a two-step structure: share contribution to New Pubco (Irish Holdco) followed by SPAC merger.
- Upfront equity consideration: 21,985,971 New Pubco ordinary shares at $10.00 stated value to Blue Finance shareholders.
- HSC receives 814,029 shares and MFC Tech receives 1,200,000 shares at $0.0001 per share via subscription agreements.
- Earnout: up to 3,000,000 shares at $15.00 VWAP milestone and up to 3,000,000 shares at $1B market cap milestone, over 5 years.
- Aggregate share cap across upfront and contingent issuances: 30,000,000 shares.
- Closing conditions include IVCA shareholder approval, F-4 effectiveness, Nasdaq listing, and regulatory approvals; outside date November 4, 2026.
- Sponsor (Samara Special Opportunities) agreed to vote in favor and not redeem; lock-up of 12 months for certain holders.
Financial Impact
No financial impact from this amendment. Deal consideration unchanged: 21,985,971 shares at $10.00 stated value (~$219.9M upfront), plus earnout shares up to 6,000,000 additional shares.
Risk Factors
- Deal completion risk: subject to shareholder approval, regulatory clearances, and Nasdaq listing.
- SPAC de-SPAC execution risk: no financials disclosed for Blue Finance; earnout milestones may not be achieved.
- OTC Pink Sheets listing limits liquidity and institutional interest until Nasdaq listing.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001829126-26-004201 |
| Document: 0001829126-26-004201-index-headers.html | 0001829126-26-004201 |
| Document: 0001829126-26-004201-index.html | 0001829126-26-004201 |
| Document: 0001829126-26-004201.txt | 0001829126-26-004201 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Apr 30, 2026
6w ago
|
425
| $12.00 $12.00 | · 0.00% | ▼ −5.23% | $12.00 (0.00%) |
|
Apr 13, 2026
8w ago
|
8-K / 425
| $12.00 $12.00 | · 0.00% | ▼ −6.30% | $12.00 (0.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access